Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics (COVADIS)
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
Most of the patients were already vaccinated
A observational or N/A phase clinical study on Autoimmune Diseases and Inflammatory Disorder, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Terminated
-
Oct 2025 — Present [monthly]
Terminated
-
Sep 2024 — Oct 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2023 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
▶ Show 2 earlier versions
-
Dec 2021 — Jan 2023 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Immunov
- URC-CIC Paris Descartes Necker Cochin
For direct contact, visit the study record on ClinicalTrials.gov .